FluoretiQ

Country: Scotland

What infection type does your test focus on? Urinary Tract Infection

What does your test detect? Pathogen (s), Antibiotic Susceptibility Pattern

About the Team: 

FluoretiQ is a multi-award winning, UK start-up founded by Dr. Neciah Dorh, Josephine Dorh and Prof. Martin Cryan. Since being founded in 2017, FluoretiQ has built an interdisciplinary team of scientists, engineers and business leaders to tackle major diagnostic challenges, with active projects in both infectious disease and oncology diagnostics. Our first product is codenamed P5; a 15-minute, POC diagnostic test that uses NANOPLEX technology to identify and enumerate UTI-causing bacteria with over 90% sensitivity and specificity. The P5 product line will enable optimal antibiotic treatment from the first consultation.  NANOPLEX is a 15-minute assay that uses synthetic glycan-coated latex microspheres to mimic the glycan-binding interaction between host and pathogen. Put simply, bacteria recognise specific sugars (glycans) in the body to establish infection. FluoretiQ has recreated these sugars and modified the way they appear on our probes, so that bacteria continue to recognise them. Using this approach, FluoretiQ’s products will reduce the time to correctly diagnose bacterial infections from 2 days to 15 minutes.

Twitter: @fluoretiq